Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
CNY 4.56
(-2.36%)
CNY 4.56
(-2.36%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 656.89 Million CNY | -21.86% |
| 2022 | 840.65 Million CNY | 3.63% |
| 2021 | 811.18 Million CNY | -7.6% |
| 2020 | 877.91 Million CNY | -34.68% |
| 2019 | 1.34 Billion CNY | -48.02% |
| 2018 | 2.58 Billion CNY | 0.08% |
| 2017 | 2.58 Billion CNY | -2.15% |
| 2016 | 2.64 Billion CNY | 7.38% |
| 2015 | 2.45 Billion CNY | 25.63% |
| 2014 | 1.95 Billion CNY | 1069.96% |
| 2013 | 167.3 Million CNY | 15.17% |
| 2012 | 145.26 Million CNY | 4.49% |
| 2011 | 139.03 Million CNY | -36.05% |
| 2010 | 217.38 Million CNY | -8.03% |
| 2009 | 236.37 Million CNY | 9.03% |
| 2008 | 216.8 Million CNY | 15.49% |
| 2007 | 187.73 Million CNY | -21.0% |
| 2006 | 237.62 Million CNY | 10.82% |
| 2005 | 214.42 Million CNY | -17.07% |
| 2004 | 258.56 Million CNY | 19.08% |
| 2003 | 217.12 Million CNY | 1.25% |
| 2002 | 214.44 Million CNY | 25.23% |
| 2001 | 171.24 Million CNY | -9.52% |
| 2000 | 189.27 Million CNY | 39.18% |
| 1999 | 135.98 Million CNY | 57.43% |
| 1998 | 86.38 Million CNY | 31.1% |
| 1997 | 65.88 Million CNY | -3.95% |
| 1996 | 68.59 Million CNY | 1.66% |
| 1995 | 67.47 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 102 Million CNY | 1.42% |
| 2024 Q1 | 100.57 Million CNY | -2.41% |
| 2024 Q3 | 91.48 Million CNY | -9.68% |
| 2023 Q2 | 204.46 Million CNY | 16.14% |
| 2023 Q4 | 103.06 Million CNY | -40.53% |
| 2023 Q1 | 176.05 Million CNY | -23.06% |
| 2023 FY | 656.89 Million CNY | -21.86% |
| 2023 Q3 | 173.31 Million CNY | -15.24% |
| 2022 Q1 | 181.4 Million CNY | -27.85% |
| 2022 Q2 | 220.6 Million CNY | 21.61% |
| 2022 Q3 | 209.81 Million CNY | -4.89% |
| 2022 FY | 840.65 Million CNY | 3.63% |
| 2022 Q4 | 228.83 Million CNY | 9.07% |
| 2021 Q3 | 246.22 Million CNY | 27.8% |
| 2021 Q4 | 251.41 Million CNY | 2.11% |
| 2021 FY | 811.18 Million CNY | -7.6% |
| 2021 Q1 | 120.86 Million CNY | 306.33% |
| 2021 Q2 | 192.66 Million CNY | 59.4% |
| 2020 Q3 | 371.66 Million CNY | 44.59% |
| 2020 FY | 877.91 Million CNY | -34.68% |
| 2020 Q1 | 307.77 Million CNY | -1.01% |
| 2020 Q2 | 257.05 Million CNY | -16.48% |
| 2020 Q4 | -58.57 Million CNY | -115.76% |
| 2019 Q2 | 394.61 Million CNY | 33.94% |
| 2019 FY | 1.34 Billion CNY | -48.02% |
| 2019 Q4 | 310.92 Million CNY | -9.58% |
| 2019 Q3 | 343.86 Million CNY | -12.86% |
| 2019 Q1 | 294.62 Million CNY | -73.06% |
| 2018 Q4 | 1.09 Billion CNY | 114.59% |
| 2018 Q1 | 382.98 Million CNY | -67.82% |
| 2018 Q3 | 509.68 Million CNY | -14.95% |
| 2018 FY | 2.58 Billion CNY | 0.08% |
| 2018 Q2 | 599.31 Million CNY | 56.49% |
| 2017 Q2 | 554.44 Million CNY | 56.91% |
| 2017 FY | 2.58 Billion CNY | -2.15% |
| 2017 Q1 | 353.35 Million CNY | -70.51% |
| 2017 Q4 | 1.19 Billion CNY | 144.95% |
| 2017 Q3 | 485.83 Million CNY | -12.38% |
| 2016 FY | 2.64 Billion CNY | 7.38% |
| 2016 Q2 | 583.31 Million CNY | 45.79% |
| 2016 Q4 | 1.19 Billion CNY | 160.97% |
| 2016 Q1 | 400.1 Million CNY | -59.78% |
| 2016 Q3 | 459.06 Million CNY | -21.3% |
| 2015 Q1 | 357.65 Million CNY | -81.0% |
| 2015 Q3 | 500.25 Million CNY | -17.51% |
| 2015 Q4 | 994.67 Million CNY | 98.83% |
| 2015 FY | 2.45 Billion CNY | 25.63% |
| 2015 Q2 | 606.44 Million CNY | 69.56% |
| 2014 Q2 | 28.99 Million CNY | 43.13% |
| 2014 FY | 1.95 Billion CNY | 1069.96% |
| 2014 Q4 | 1.88 Billion CNY | 7138.51% |
| 2014 Q3 | 26 Million CNY | -10.31% |
| 2014 Q1 | 20.25 Million CNY | -67.43% |
| 2013 Q1 | 22.63 Million CNY | -60.3% |
| 2013 Q3 | 35.94 Million CNY | -22.76% |
| 2013 FY | 167.3 Million CNY | 15.17% |
| 2013 Q4 | 62.18 Million CNY | 73.01% |
| 2013 Q2 | 46.53 Million CNY | 105.58% |
| 2012 Q3 | 23.43 Million CNY | -43.01% |
| 2012 FY | 145.26 Million CNY | 4.49% |
| 2012 Q2 | 41.12 Million CNY | 73.66% |
| 2012 Q1 | 23.68 Million CNY | -46.44% |
| 2012 Q4 | 57.02 Million CNY | 143.3% |
| 2011 Q1 | 37.87 Million CNY | -33.53% |
| 2011 Q2 | 34.87 Million CNY | -7.91% |
| 2011 Q3 | 22.05 Million CNY | -36.76% |
| 2011 FY | 139.03 Million CNY | -36.05% |
| 2011 Q4 | 44.21 Million CNY | 100.45% |
| 2010 Q4 | 56.97 Million CNY | -4.32% |
| 2010 FY | 217.38 Million CNY | -8.03% |
| 2010 Q2 | 43.33 Million CNY | -24.67% |
| 2010 Q1 | 57.53 Million CNY | -29.28% |
| 2010 Q3 | 59.54 Million CNY | 37.41% |
| 2009 Q3 | 57.74 Million CNY | 3.33% |
| 2009 FY | 236.37 Million CNY | 9.03% |
| 2009 Q2 | 55.88 Million CNY | 35.03% |
| 2009 Q1 | 41.38 Million CNY | 3.92% |
| 2009 Q4 | 81.35 Million CNY | 40.88% |
| 2008 FY | 216.8 Million CNY | 15.49% |
| 2008 Q3 | 43.79 Million CNY | -37.77% |
| 2008 Q2 | 70.37 Million CNY | 12.07% |
| 2008 Q4 | 39.82 Million CNY | -9.06% |
| 2008 Q1 | 62.79 Million CNY | 29.26% |
| 2007 Q3 | 44.94 Million CNY | 22.68% |
| 2007 Q1 | 57.57 Million CNY | -25.24% |
| 2007 Q4 | 48.58 Million CNY | 8.1% |
| 2007 FY | 187.73 Million CNY | -21.0% |
| 2007 Q2 | 36.63 Million CNY | -36.37% |
| 2006 Q4 | 77 Million CNY | 56.55% |
| 2006 Q2 | 54.94 Million CNY | -2.74% |
| 2006 Q1 | 56.48 Million CNY | -34.88% |
| 2006 FY | 237.62 Million CNY | 10.82% |
| 2006 Q3 | 49.18 Million CNY | -10.47% |
| 2005 Q2 | 43.15 Million CNY | 0.38% |
| 2005 Q3 | 41.54 Million CNY | -3.73% |
| 2005 FY | 214.42 Million CNY | -17.07% |
| 2005 Q4 | 86.74 Million CNY | 108.82% |
| 2005 Q1 | 42.98 Million CNY | -57.44% |
| 2004 Q3 | 59.5 Million CNY | 41.53% |
| 2004 Q1 | 56 Million CNY | 7.21% |
| 2004 Q2 | 42.04 Million CNY | -24.93% |
| 2004 Q4 | 101.01 Million CNY | 69.75% |
| 2004 FY | 258.56 Million CNY | 19.08% |
| 2003 Q1 | 42.3 Million CNY | -48.43% |
| 2003 FY | 217.12 Million CNY | 1.25% |
| 2003 Q4 | 52.23 Million CNY | -17.98% |
| 2003 Q3 | 63.68 Million CNY | 8.12% |
| 2003 Q2 | 58.89 Million CNY | 39.21% |
| 2002 Q1 | 33.24 Million CNY | 0.0% |
| 2002 FY | 214.44 Million CNY | 25.23% |
| 2002 Q4 | 82.04 Million CNY | 40.07% |
| 2002 Q3 | 58.57 Million CNY | 44.34% |
| 2002 Q2 | 40.58 Million CNY | 22.07% |
| 2001 FY | 171.24 Million CNY | -9.52% |
| 2000 FY | 189.27 Million CNY | 39.18% |
| 1999 FY | 135.98 Million CNY | 57.43% |
| 1998 FY | 86.38 Million CNY | 31.1% |
| 1997 FY | 65.88 Million CNY | -3.95% |
| 1996 FY | 68.59 Million CNY | 1.66% |
| 1995 FY | 67.47 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 32.05 Billion CNY | 97.951% |
| Zhejiang Zhenyuan Share Co., Ltd. | 4.1 Billion CNY | 84.003% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 737.81 Million CNY | 10.968% |
| Yifan Pharmaceutical Co., Ltd. | 4.02 Billion CNY | 83.668% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 533.23 Million CNY | -23.191% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 21.15 Billion CNY | 96.894% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 895.59 Million CNY | 26.653% |
| Boai NKY Medical Holdings Ltd. | 1.58 Billion CNY | 58.514% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 848.19 Million CNY | 22.553% |